Afghanistan vs Pakistan: Antiretroviral therapy coverage for PMTCT
Afghanistan
14.0%
in 2024
Pakistan
14.0%
in 2024
Afghanistan rank
81st
Pakistan rank
81st
Antiretroviral therapy coverage for PMTCT over time
- Afghanistan
- Pakistan
How they compare
Afghanistan currently reports 14.0% against 14.0% in Pakistan, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Pakistan ahead.
Afghanistan ranks 81st and Pakistan ranks 81st of 84 countries.
Across the 3 decades both report, Afghanistan averaged higher in 2 and Pakistan in 1.
Head to head by decade
| Decade | Afghanistan | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 0.7% | 0.4% | Pakistan |
| 2010s | 8.9% | 7.2% | 1.7% | Afghanistan |
| 2020s | 21.4% | 10.4% | 11.0% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Afghanistan or Pakistan?
- Afghanistan, at 14.0% against 14.0% in Pakistan as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Afghanistan and Pakistan?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Pakistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Pakistan rank globally for antiretroviral therapy coverage for pmtct?
- Afghanistan ranks 81st and Pakistan ranks 81st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).